No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.

• Erasca, Inc.
• Oruka Therapeutics, Inc.
• Xenon Pharmaceuticals Inc.
• PTC Therapeutics, Inc.
• Scholar Rock Holding Corporation
• Caris Life Sciences, Inc.
• Mirum Pharmaceuticals, Inc.
• CG Oncology Inc.